Table of Content

1 Biologics Market Introduction and Overview
1.1 Biologics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Biologics Industry Dynamic Analysis
1.5.1 Biologics Market Trends Analysis
1.5.2 Biologics Market Drivers Analysis
1.5.3 Biologics Market Challenges Analysis
1.5.4 Biologics Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Biologics Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Biologics Revenue and Share by Type
3 Global Biologics Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Biologics Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Biologics Market Size (2019-2024)
4.2 Biologics Growth Insights by Regions
4.2.1 Biologics Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Biologics Revenue Market Size by Regions (2019-2024)
4.2.3 North America Biologics Market Size (2019-2024)
4.2.4 Europe Biologics Market Size (2019-2024)
4.2.5 Asia-Pacific Biologics Market Size (2019-2024)
4.2.6 Latin America Biologics Market Size (2019-2024)
4.2.7 Middle East & Africa Biologics Market Size (2019-2024)
5 North America
5.1 North America Biologics Revenue by Countries
5.1.1 North America Biologics Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Biologics Revenue by Countries
6.1.1 Asia Pacific Biologics Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Biologics Revenue by Countries
7.1.1 Europe Biologics Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Biologics Revenue by Countries
8.1.1 Latin America Biologics Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Biologics Revenue by Countries
9.1.1 Middle East & Africa Biologics Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Biologics Market Competition, by Players
10.1 Global Biologics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Biologics Players Market Share in 2023
10.2.2 Top 6 Biologics Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Biologics Players Head Office, Business Provided
10.4 Biologics Mergers & Acquisitions
10.5 Biologics New Entrants and Expansion Plans
11 Players Profiles
11.1 Merck
11.1.1 Merck Company Profile
11.1.2 Biologics Product Overview
11.1.3 Merck Biologics Market Performance (2019-2024)
11.1.4 Merck Business Overview
11.1.5 Recent Developments and Plans
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Profile
11.2.2 Biologics Product Overview
11.2.3 Johnson & Johnson Biologics Market Performance (2019-2024)
11.2.4 Johnson & Johnson Business Overview
11.2.5 Recent Developments and Plans
11.3 Sanofi
11.3.1 Sanofi Company Profile
11.3.2 Biologics Product Overview
11.3.3 Sanofi Biologics Market Performance (2019-2024)
11.3.4 Sanofi Business Overview
11.3.5 Recent Developments and Plans
11.4 Bristol-Myers Squibb.
11.4.1 Bristol-Myers Squibb. Company Profile
11.4.2 Biologics Product Overview
11.4.3 Bristol-Myers Squibb. Biologics Market Performance (2019-2024)
11.4.4 Bristol-Myers Squibb. Business Overview
11.4.5 Recent Developments and Plans
11.5 Catalent
11.5.1 Catalent Company Profile
11.5.2 Biologics Product Overview
11.5.3 Catalent Biologics Market Performance (2019-2024)
11.5.4 Catalent Business Overview
11.5.5 Recent Developments and Plans
11.6 AbbVie
11.6.1 AbbVie Company Profile
11.6.2 Biologics Product Overview
11.6.3 AbbVie Biologics Market Performance (2019-2024)
11.6.4 AbbVie Business Overview
11.6.5 Recent Developments and Plans
11.7 Takeda
11.7.1 Takeda Company Profile
11.7.2 Biologics Product Overview
11.7.3 Takeda Biologics Market Performance (2019-2024)
11.7.4 Takeda Business Overview
11.7.5 Recent Developments and Plans
11.8 Novartis
11.8.1 Novartis Company Profile
11.8.2 Biologics Product Overview
11.8.3 Novartis Biologics Market Performance (2019-2024)
11.8.4 Novartis Business Overview
11.8.5 Recent Developments and Plans
12 Global Biologics Forecast Market Insights by Type
12.1 Global Biologics Revenue Market Forecast by Type (2024-2030)
13 Global Biologics Forecast Market Insights by Application
13.1 Biologics Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Biologics Forecast Market Size (2024-2030)
14.2 Biologics Growth Forecast Insights by Regions
14.2.1 Biologics Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Biologics Forecast Market Size (2024-2030)
14.2.3 Europe Biologics Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Biologics Forecast Market Size (2024-2030)
14.2.5 Latin America Biologics Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Biologics Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer